Luigi Costa, Noema Pharma CEO
March 7, 2023 02:00 AM ESTUpdated 05:36 AM
Financing
R&D

Noe­ma Phar­ma rais­es $112M Se­ries B to ad­vance CNS dis­or­der pipeline with Roche can­di­dates

Katherine Lewin

News Reporter

Swiss biotech Noe­ma Phar­ma jump­start­ed back in 2020 with a $60 mil­lion Se­ries A fi­nanc­ing round. To­day, it’s wrap­ping up its Se­ries B round with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Ab­b­Vie fi­nal­ly en­ters obe­si­ty race with $350M up­front for Gubra’s amylin

Af­ter Phase 3 de­pres­sion set­back, Neumo­ra paus­es two tri­als to make changes, scraps an­oth­er

AD­Cs from a decade-old Sin­ga­pore biotech find new life with $187M

No­vo Nordisk signs $354M part­ner­ship with AI-guid­ed biotech for ‘risky’ new meta­bol­ic mech­a­nisms

Pro­tag­o­nist, Takeda's prof­it shar­ing deal un­der spot­light af­ter Phase 3 blood dis­or­der tri­al win

sponsored

The per­fect storm: Why every­thing is in place for 2025 to be the year of GxP AI

A service from the Financial Times